CAS: 19888-56-3; Fluazacort

该化合物是一种具有抗炎和免疫抑制特性的合成可乐类固醇,主要用于治疗各种炎症和自发性症状,其特点是能够调节免疫反应,减少炎症,从而有效地管理风湿类动脉炎,肺炎和某些皮肤病等疾病.氟甲酸盐与其他可乐类固醇相比,其作用相对较低,有助于最大限度地减少液体保留和高血压等副作用.该化合物通常通过口服施用,在胃肠道中吸收,其药理效应归因于其与甘油感应器的相互作用,导致调控炎和免疫反应中涉及的基因表达.此外,氟甲酸盐具有有利的安全性特征,其不良效应的发生率比传统可乐类固醇低,因此在长期治疗慢性病时选择它为首选.它与所有可花类固剂相关的重要作用是谨慎监测,与降低长期作用.

结构式图片

MSDS等安全信息

    上下游产品

    CAS号13649-87-1 3β-acetoxy-11β-... | CAS号16119-56-5 21-hydroxy-2'-m... | CAS号108-24-7 乙酸酐 | CAS号14484-48-1 9-fluoro-11β,21...

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-12391691-B2
      优先权日:2018-11-16
      标题:Synthesis of key intermediate of KRAS G12C inhibitor compound
      发明人:PARSONS ANDREW THOMAS; COCHRAN BRIAN MCNEIL; POWAZINIK IV WILLIAM; CAPORINI MARC ANTHONY
      权利人:AMGEN INC
      摘要:The present invention relates to an improved, efficient, scalable process to prepare intermediate compounds, such as compound 5M, having the structure n nuseful for the synthesis of compounds that target KRAS G12C mutations, such as

      专利号:US-2025206736-A1
      优先权日:2019-11-14
      标题 :Synthesis of kras g12c inhibitor compound
      发明人:CORBETT MICHAEL THOMAS; CAILLE SEBASTIEN
      权利人:AMGEN INC
      摘要:The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2-isopropyl-4-methylpyridin-3-amine, useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers.

      专利号:US-9051302-B2
      优先权日:2008-01-15
      标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
      发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
      权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
      摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

      专利号:US-2013035307-A1
      优先权日:2010-01-26
      标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
      发明人:PRESTWICH GLENN D; KENNEDY THOMAS P
      权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P
      摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.

      专利号:US-2024287041-A1
      优先权日:2021-05-20
      标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
      发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

      专利号:WO-2023096715-A9
      优先权日:2021-10-22
      标 题:Immunomodulatory glycosphingolipids and methods of use thereof
      发明人:KASPER DENNIS; OH SUNGWHAN
      权利人:HARVARD COLLEGE
      摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Medicamentos de Actualidad., 12(396), 1976
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知